In the News / Politics

FDA Approves edaravone (Radicava™) to Treat ALS

By: Thanesha Graham, PharmD Candidate c/o 2019 - Amyotrophic lateral sclerosis (ALS) is commonly referred to as Lou Gehrig’s disease.…

9 years ago

The Prior Authorization Process and its Effect on Patient Care

By: Zachary Reale, PharmD Candidate c/o 2018 - Today there are over fifty oral anticancer agents on the market and…

9 years ago

Valbenazine (Ingrezza®): The First FDA Approved Drug for Tardive Dyskinesia

By: Yan Yi Chan, PharmD Candidate c/o 2018 - Tardive dyskinesia is a movement disorder characterized by involuntary and repetitive…

9 years ago

Lifitegrast: an alternative treatment for dry eye disease

By: Vicky Liu, PharmD Candidate c/o 2018 - On July 11, 2016, lifitegrast (Xiidra®), the first lymphocyte function-associated antigen 1…

9 years ago

Two hepatitis C drugs approved for pediatric use

By: Anna Diyamandoglu, PharmD Candidate c/o 2020 - Hepatitis C is an infectious disease which is caused by the hepatitis…

9 years ago

A review on potassium iodide in radiological disasters

By: Victoria Hom, PharmD Candidate c/o 2018 - This year marked the 31st anniversary of Chernobyl, the worst nuclear disaster…

9 years ago

Biosimiliars: how will they affect the pharmacoeconomics of health care?

By: Kenny Chan, PharmD - Competition is the greatest driver of innovation and cost savings. The U.S. health care system…

9 years ago

Rocket (Health) Science: Pharmaceutical Challenges at the Johnson Space Center

By: Kimberly Lapierre, PharmD Candidate c/o 2017 - Since its inception in 2003, the Johnson Space Center Pharmacy has taken…

9 years ago

2017’s Immunization Guidelines Officially Released by the CDC

By: Gabrielle Flavoni, PharmD Candidate c/o 2018 - The release of this year's updated immunization schedule has sent a buzz…

9 years ago

FDA Approves Obiltoxaximab (Anthim®) Injection for Inhalational Anthrax

By: Alex Chu, Staff Writer - On March 21 2016, the Food and Drug Administration (FDA) approved obiltoxaximab (Anthim®), an…

10 years ago